Three-Year Clinical Follow-Up of the Unrestricted Use of Sirolimus-Eluting Stents as Part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) Registry
Joost Daemen, Andrew T.L. Ong, Giulio Stefanini, Keiichi Tsuchida, Helle Spindler, Georgios Sianos, Peter P.T. de Jaegere, Ron T. van Domburg, Patrick W. Serruys (2006). Three-Year Clinical Follow-Up of the Unrestricted Use of Sirolimus-Eluting Stents as Part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) Registry. The American Journal of Cardiology, 98(7), pp. 895-901, DOI: 10.1016/j.amjcard.2006.04.031.
